RLMD
Relmada Therapeutics, Inc. · Healthcare
Director Paul Edward Kelly bought $150K of Relmada Therapeutics, Inc.
Bought$150,000
$1.50Price
100,000Shares
+26%Stake
What RLMD did for a copier
Prices for RLMD after this filing aren't in yet.
Paul Edward Kelly's record
3 other buys with 3 months of prices since 2018: on average −18.3% against the S&P 500, and 1 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, May 14. Filed Wed, May 15, 12:07 PM ET, during the session. Not investment advice.